Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells
Crossref DOI link: https://doi.org/10.1007/s00262-014-1561-8
Published Online: 2014-05-31
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kosaka, Akemi
Ohkuri, Takayuki
Okada, Hideho
Text and Data Mining valid from 2014-05-31